ANTI-PD-1-ANTIKÖRPER

European patent · EP3512885 · In force

Register entry

Publication number
EP3512885
Application number
EP17851358
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 9, 2017
Published
Jul 24, 2019
Granted
Feb 21, 2024
Protection ends at the latest
Sep 8, 2037
Next annual fee due
Sep 30, 2027
IPC classes
C07K 16/28 (2006.01)
C07K 16/18 (2006.01)
A61K 49/16 (2006.01)
A61K 51/10 (2006.01)
A61K 39/395 (2006.01)
A61K 47/68 (2017.01)
A61P 35/00 (2006.01)
G01N 33/563 (2006.01)
Priority
US 201662395832 P 16.09.2016
US 201762519590 P 14.06.2017
PCT application
PCT/US2017/050851 09.09.2017
PCT publication
WO2018/052818 22.03.2018
Filing language
English
Source
Swissreg

Supplementary protection certificates

A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  4. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  5. Feb 21, 2024

    Granted

    Published in Swissreg on 21.02.2024

Parties

Inventor

LIN, Pei-Hua

Shanghai, CN

JIANG, Weidong

Shanghai, CN

TSENG, Chi-Ling

Shanghai, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.